B, T., A, Y., & DF, M. (2026). Repurposing therapies in junctional epidermolysis bullosa: Oral ivermectin therapy associated with improved wound healing and reduced pruritus. JAAD case reports, 74, 218. https://doi.org/10.1016/j.jdcr.2026.06.019
Chicago Style (17th ed.) CitationB, Tan, Yang A, and Murrell DF. "Repurposing Therapies in Junctional Epidermolysis Bullosa: Oral Ivermectin Therapy Associated with Improved Wound Healing and Reduced Pruritus." JAAD Case Reports 74 (2026): 218. https://doi.org/10.1016/j.jdcr.2026.06.019.
MLA (9th ed.) CitationB, Tan, et al. "Repurposing Therapies in Junctional Epidermolysis Bullosa: Oral Ivermectin Therapy Associated with Improved Wound Healing and Reduced Pruritus." JAAD Case Reports, vol. 74, 2026, p. 218, https://doi.org/10.1016/j.jdcr.2026.06.019.